Volume 19, Number 3—March 2013
Dispatch
Virulence of Pertactin-Negative Bordetella pertussis Isolates from Infants, France
Hélène Bodilis1 and Nicole Guiso
Table 2
Clinical signs and symptoms of vaccinated and unvaccinated pertussis patients, France, 2004–2007
| Characteristics |
No. patients/no. with characteristic (%) |
p value* |
|
|---|---|---|---|
| Not vaccinated, n = 46 |
Received 1–2 doses, n = 12 |
||
| Intensive care admission | 18/34 (53) | 0/11 (0) | 0.001 |
| Apnea | 15/25 (60) | 1/7 (14) | 0.08 |
| Cyanosis/desaturation | 24/28 (86) | 5/8 (62) | 0.167 |
| Syncopal episodes | 12/26 (46) | 0/8 (0) | 0.03 |
| Bradycardia | 15/21 (71) | 3/6 (50) | 0.367 |
| Deterioration of general condition | 12/29 (41) | 2/8 (25) | 0.68 |
| Malignant pertussis | 1/29 (3) | 0/8 (0) | 1.0 |
*By Fisher exact test.
1Current affiliation: Cochin Hospital, Paris, France
Page created: February 27, 2013
Page updated: February 27, 2013
Page reviewed: February 27, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.